Click on the company for more information on the subsidy award. Click on the parent name to reach the summary page for that parent company.
Company | Parent | Location | Subsidy Source | Year | Subsidy Value | Loan/Bailout Value | Type of Subsidy |
---|---|---|---|---|---|---|---|
Hospira, Inc. and Subsidiaries | Pfizer | Illinois | state | 2007 | $404,000 | tax credit/rebate | |
GILEAD SCIENCES INC | Gilead Sciences | Washington | state | 2014 | $403,872 | tax credit/rebate | |
Centocor Research & Development, Inc. | Johnson & Johnson | Pennsylvania | state | 2009 | $402,833 | tax credit/rebate | |
Regeneron Pharmaceuticals | Regeneron Pharmaceuticals | New York | local | 2011 | $402,482 | tax credit/rebate; property tax abatement | |
Doral/Pfizer | Pfizer | New York | local | 2015 | $402,469 | tax credit/rebate | |
Doral/Pfizer | Pfizer | New York | local | 2016 | $402,469 | tax credit/rebate | |
Shire Pharmaceuticals Inc. | Takeda Pharmaceutical | Pennsylvania | state | 2008 | $402,051 | tax credit/rebate | |
Abraxis BioScience | Bristol-Myers Squibb | Iowa | state | 2008 | $400,000 | grant/loan hybrid program | |
Teva Pharmaceuticals USA, Inc. | Teva Pharmaceutical Industries | Pennsylvania | state | $400,000 | grant | ||
C3i Incorporated | Merck | Pennsylvania | state | $400,000 | grant | ||
Novavax, Inc. | Novavax Inc. | Pennsylvania | state | $400,000 | grant | ||
Barr Laboratories, Inc. | Teva Pharmaceutical Industries | Virginia | state | 2008 | $400,000 | grant | |
OMEROS CORP | Omeros Corp. | Washington | state | 2014 | $398,897 | tax credit/rebate | |
OMEROS CORPORATION | Omeros Corp. | Washington | state | 2015 | $398,897 | tax credit/rebate | |
GLAXOSMITHKLINE BIOLOGICALS NORTH AMERICA | GlaxoSmithKline | Washington | state | 2006 | $397,686 | tax credit/rebate | |
MILLIPORE CORPORATION | Merck KGaA (EMD) | Missouri | state | 2011 | $397,131 | tax credit/rebate | |
Albany Molecular | Curia Inc. | New York | local | 2011 | $395,043 | tax credit/rebate; property tax abatement | |
LAX/Amneal Pharmaceuticals | Amneal Pharmaceuticals | New York | local | 2013 | $393,986 | tax credit/rebate; property tax abatement | |
Bristol-Myers Squibb | Bristol-Myers Squibb | New York | local | 2012 | $393,682 | tax credit/rebate; property tax abatement | |
Bristol-Myers Squibb | Bristol-Myers Squibb | New York | local | 2020 | $390,921 | tax credit/rebate | |
Bristol-Myers Squibb | Bristol-Myers Squibb | New York | local | 2019 | $390,739 | tax credit/rebate | |
AMRI Rensselaer, Inc. | Curia Inc. | New York | state | 2012 | $390,683 | enterprise zone | |
Bristol-Myers Squibb | Bristol-Myers Squibb | New York | local | 2021 | $390,427 | tax credit/rebate | |
CENTOCOR BIOLOGICS, LLC SERIES 2005 | Johnson & Johnson | Missouri | state | 2006 | $386,661 | tax credit/rebate | |
Idexx Laboratories, Inc. | IDEXX Laboratories | Maine | state | 2018 | $385,883 | tax credit/rebate | |
MacroGenics, Inc. | MacroGenics | Maryland | state | 2017 | $385,562 | tax credit/rebate | |
Novartis Pharmaceuticals Corp. | Novartis | North Carolina | state | 2019 | $385,031 | tax credit/rebate | |
Abbott Laboratories | Abbott Laboratories | Illinois | state | 2006 | $381,909 | tax credit/rebate | |
ZYMOGENETICS INC | Bristol-Myers Squibb | Washington | state | 2006 | $380,245 | tax credit/rebate | |
Abbott Laboratories | Abbott Laboratories | Illinois | state | 2005 | $378,187 | tax credit/rebate | |
ZYMOGENETICS INC | Bristol-Myers Squibb | Washington | state | 2005 | $375,100 | tax credit/rebate | |
Bausch & Lomb Incorporated | Bausch Health | New York | state | 2013 | $375,037 | enterprise zone | |
OSI Pharmaceuticals LLC | Astellas Pharma | New York | local | 2013 | $374,233 | tax credit/rebate; property tax abatement | |
Wyeth Holdings Corporation | Pfizer | North Carolina | state | 2010 | $373,801 | tax credit/rebate | |
Amneal Pharmaceutical of NY, LLC | Amneal Pharmaceuticals | New York | state | 2012 | $372,801 | enterprise zone | |
Novozymes North America, Inc. | Novo Holdings A/S | North Carolina | state | 2010 | $372,272 | tax credit/rebate | |
Forest Research Institute, Inc. | AbbVie | Pennsylvania | state | 2013 | $369,915 | tax credit/rebate | |
Nupathe, Inc. | Teva Pharmaceutical Industries | Pennsylvania | state | 2008 | $369,626 | tax credit/rebate | |
Gilead Sciences, Inc. | Gilead Sciences | North Carolina | state | 2010 | $367,742 | tax credit/rebate | |
Sanofi Pasteur Inc. (fka Aventis Pasteur Inc.) | Sanofi | Pennsylvania | state | 2008 | $363,760 | tax credit/rebate | |
Regeneron Pharmaceuticals, Inc. | Regeneron Pharmaceuticals | New York | state | 2009 | $363,019 | enterprise zone | |
AMRI Rensselaer, Inc. | Curia Inc. | New York | state | 2011 | $363,000 | enterprise zone | |
Bristol-Myers Squibb | Bristol-Myers Squibb | New York | local | 2009 | $361,233 | tax credit/rebate; property tax abatement | |
Regeneron CSC Way Project | Regeneron Pharmaceuticals | New York | local | 2020 | $361,165 | tax credit/rebate | |
Regeneron 1 CSC Way Project | Regeneron Pharmaceuticals | New York | local | 2020 | $361,165 | tax credit/rebate | |
Doral/Pfizer | Pfizer | New York | local | 2011 | $360,540 | tax credit/rebate; property tax abatement | |
Forest Laboratories, Inc. and Forest Research | AbbVie | New Jersey | state | 1999 | $360,150 | grant | |
ABBOTT DIABETES CARE | Abbott Laboratories | California | state | 2007 | $359,454 | training reimbursement | |
Bristol-Myers Squibb | Bristol-Myers Squibb | New York | local | 2008 | $358,648 | tax credit/rebate; property tax abatement | |
Doral/Pfizer | Pfizer | New York | local | 2012 | $357,613 | tax credit/rebate; property tax abatement | |
Bristol Myers Squibb (Mr. Leon Squibb) | Bristol-Myers Squibb | New York | local | 2004 | $355,511 | tax credit/rebate; property tax abatement | |
AMRI Rensselaer, Inc. | Curia Inc. | New York | state | 2008 | $353,143 | enterprise zone | |
ZYMOGENETICS INC | Bristol-Myers Squibb | Washington | state | 2009 | $351,337 | tax credit/rebate | |
Takeda Pharmaceuticals North America, Inc. | Takeda Pharmaceutical | Illinois | state | 2006 | $350,000 | grant | |
Takeda Pharmaceuticals North America, Inc. | Takeda Pharmaceutical | Illinois | state | 2007 | $350,000 | grant | |
ImClone Systems | Eli Lilly | New Jersey | state | 2010 | $350,000 | tax credit/rebate | |
Daiichi Sankyo, Inc. | Daiichi Sankyo | Pennsylvania | state | $350,000 | grant | ||
Albany Molecular Research, Inc. | Curia Inc. | Indiana | state | 2013 | $350,000 | tax credit/rebate | |
CSL Behring | CSL Limited | Pennsylvania | state | $350,000 | grant | ||
Novartis Vaccines & Diagnostics, Inc. | Novartis | North Carolina | state | 2012 | $347,213 | tax credit/rebate | |
Novartis Vaccines & Diagnostics, Inc | Novartis | North Carolina | state | 2014 | $347,000 | grant | |
Regeneron Pharmaceuticals, Inc. | Regeneron Pharmaceuticals | New Jersey | state | 2011 | $345,900 | grant | |
Celgene | Bristol-Myers Squibb | New Jersey | state | 2005 | $345,800 | tax credit/rebate | |
CSL Behring, LLC | CSL Limited | Pennsylvania | state | 2013 | $345,642 | tax credit/rebate | |
Teva Pharmaceuticals USA, Inc. | Teva Pharmaceutical Industries | Pennsylvania | state | $345,000 | tax credit/rebate | ||
Hospira, Inc. | Pfizer | North Carolina | state | 2011 | $344,981 | tax credit/rebate | |
ABBOTT VASCULAR, INC. | Abbott Laboratories | California | state | 2014 | $344,534 | training reimbursement | |
Boehringer Ingelheim Pharmaceuticals, Inc. | Boehringer Ingelheim | Connecticut | state | 2012 | $344,500 | tax credit/rebate | |
Synthes Spine, Inc. | Johnson & Johnson | Pennsylvania | state | 2008 | $344,128 | tax credit/rebate | |
Bristol-Myers Squibb | Bristol-Myers Squibb | New York | local | 2009 | $343,915 | tax credit/rebate; property tax abatement | |
Novartis Pharmaceuticals Corp. | Novartis | North Carolina | state | 2017 | $343,670 | tax credit/rebate | |
BOEHRINGER INGELHEIM FREMONT INC | Boehringer Ingelheim | California | state | 2019 | $343,449 | training reimbursement | |
Bristol Myers Squibb (Mr. Leon Squibb) | Bristol-Myers Squibb | New York | local | 2003 | $343,428 | tax credit/rebate; property tax abatement | |
CSL Behring, LLC | CSL Limited | Pennsylvania | state | 2012 | $342,911 | tax credit/rebate | |
PBM Covington, LLC | Perrigo | Ohio | state | 2009 | $339,354 | tax credit/rebate | |
CSL Behring | CSL Limited | Pennsylvania | state | $339,000 | tax credit/rebate | ||
CSL Behring | CSL Limited | Pennsylvania | state | 2014 | $339,000 | tax credit/rebate | |
Eli Lilly and Company | Eli Lilly | North Carolina | state | 2013 | $338,906 | tax credit/rebate | |
OSI Pharmaceuticals LLC | Astellas Pharma | New York | local | 2012 | $338,863 | tax credit/rebate; property tax abatement | |
Aventis Pharmaceuticals | Sanofi | Missouri | local | 2007 | $338,637 | tax increment financing | |
Amgen, Inc. | Amgen | Pennsylvania | state | 2009 | $336,279 | tax credit/rebate | |
Bristol-Myers Squibb | Bristol-Myers Squibb | New York | local | 2022 | $336,050 | tax credit/rebate | |
IDEXX Laboratories, Inc. | IDEXX Laboratories | Maine | state | 2010 | $334,454 | tax credit/rebate | |
ZYMOGENETICS INC | Bristol-Myers Squibb | Washington | state | 2004 | $333,589 | tax credit/rebate | |
GILEAD SCIENCES, INC. | Gilead Sciences | Washington | state | 2017 | $333,444 | tax credit/rebate | |
GILEAD SCIENCES, INC. | Gilead Sciences | Washington | state | 2018 | $333,444 | tax credit/rebate | |
AMRI Rensselaer, Inc. | Curia Inc. | New York | state | 2013 | $333,000 | enterprise zone | |
Bristol Myers Squibb (Mr. Leon Squibb) | Bristol-Myers Squibb | New York | local | 2005 | $327,383 | tax credit/rebate; property tax abatement | |
Steel Forest, LLC | AbbVie | New York | local | 2020 | $326,753 | tax credit/rebate | |
ALLERGAN INC | AbbVie | California | state | 2015 | $325,700 | training reimbursement | |
Eisai, Inc. | Eisai | New Jersey | state | 2005 | $325,500 | tax credit/rebate | |
Regeneron 1CSC Office/Lab Extension | Regeneron Pharmaceuticals | New York | local | 2019 | $322,052 | tax credit/rebate | |
Novozymes North America, Inc. | Novo Holdings A/S | North Carolina | state | 2016 | $321,201 | tax credit/rebate | |
Immunex Corporation | Amgen | Pennsylvania | state | 2013 | $319,819 | tax credit/rebate | |
Gilead Sciences, Inc. | Gilead Sciences | North Carolina | state | 2015 | $319,628 | tax credit/rebate | |
Novartis Vaccines & Diagnostics, Inc. | Novartis | North Carolina | state | 2011 | $318,349 | tax credit/rebate | |
Cambrex Charles City, Inc. | Cambrex | Iowa | state | 2013 | $318,203 | training reimbursement | |
OSI Pharmaceuticals/(OSI) Ardsley | Astellas Pharma | New York | local | 2009 | $317,597 | tax credit/rebate; property tax abatement | |
Amneal Pharmaceutical of NY, LLC | Amneal Pharmaceuticals | New York | state | 2011 | $316,824 | enterprise zone | |
GlaxoSmithKline Biologicals North America | GlaxoSmithKline | Pennsylvania | state | $316,181 | training reimbursement | ||
PFIZER, INC. | Pfizer | Missouri | state | 2000 | $315,055 | tax credit/rebate |